Abbott Laboratories
NYSE:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbott Laboratories
NYSE:ABT
|
US |
|
Grandblue Environment Co Ltd
SSE:600323
|
CN |
|
Hanover Insurance Group Inc
NYSE:THG
|
US |
|
Virgin Galactic Holdings Inc
NYSE:SPCE
|
US |
|
Safran SA
PAR:SAF
|
FR |
|
Ameris Bancorp
NASDAQ:ABCB
|
US |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
Organizacion Soriana SAB de CV
BMV:SORIANAB
|
MX |
|
Tech Mahindra Ltd
NSE:TECHM
|
IN |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 122.05 USD with a low forecast of 92.92 USD and a high forecast of 150.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
122.05
USD
According to Wall Street analysts, the average 1-year price target for ABT is 122.05 USD with a low forecast of 92.92 USD and a high forecast of 150.15 USD.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
